Traditionally combated using surgery, radiation, and chemotherapy, survival rates have improved.
But now, a new vaccine is looking to stop the cancer by harnessing the body’s immune system.
Trials for the world’s first lung cancer vaccine have started in 34 research centers across seven countries.
Senior research nurse Keenjee Nama with trial participant Janusz Racz (Photo: Aaron Chown/PA)
This method is particularly favorable because it should also strengthen the patient’s immune system.
This technology is the next big phase of cancer treatment.
Racz, who was diagnosed with lung cancer in May, remains hopeful about the treatment.
UCLH consultant medical oncologists Prof Siow-Ming Lee and Dr Sarah Benafif with trial participant Janusz Racz (Photo: Aaron Chown/PA)
